Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Deoxynucleotidyltransferase, Terminal, Interacting Protein 1 (DNTTIP1) Peptide

DNTTIP1 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN975941

Quick Overview for Deoxynucleotidyltransferase, Terminal, Interacting Protein 1 (DNTTIP1) Peptide (ABIN975941)

Target

DNTTIP1 (Deoxynucleotidyltransferase, Terminal, Interacting Protein 1 (DNTTIP1))

Origin

Human

Source

  • 1
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Characteristics

    This is a synthetic peptide designed for use in combination with anti-DNTTIP1 antibody (Catalog #: ARP50740_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    DNTTIP1 (Deoxynucleotidyltransferase, Terminal, Interacting Protein 1 (DNTTIP1))

    Background

    DNTTIP1 binds DNA and enhances the activity of terminal deoxynucleotidyltransferase (TDT, or DNTT), a DNA polymerase that catalyzes the polymerization of DNA in the absence of a DNA template.

    Alias Symbols: RP3-447F3.5, C20orf167, Tdif1, dJ447F3.4

    Protein Interaction Partner: DNTT,DNTTIP1

    Protein Size: 145

    Molecular Weight

    16 kDa

    Gene ID

    116092

    UniProt

    Q5QPF3
You are here:
Chat with us!